Poly(ADP-Ribose) Polymerase Inhibitor drugs

5 medications in the FDA established pharmacologic class “Poly(ADP-Ribose) Polymerase Inhibitor”.

DrugTypeNDC products
Talzenna
talazoparib		Rx12
Lynparza
olaparib		Rx4
Rubraca
rucaparib		Rx3
Zejula
niraparib		Rx3
Akeega
NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE		Rx2